Market Closed -
Japan Exchange
02:00:00 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
2,638
JPY
|
+0.80%
|
|
+1.97%
|
-5.79%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
164,272
|
177,714
|
259,933
|
270,685
|
203,012
|
188,899
|
-
|
-
|
Enterprise Value (EV)
1 |
152,606
|
165,740
|
250,286
|
254,568
|
190,587
|
176,412
|
173,583
|
170,151
|
P/E ratio
|
31.2
x
|
29.8
x
|
43.4
x
|
37.6
x
|
25.6
x
|
25.4
x
|
22.6
x
|
20.7
x
|
Yield
|
1.6%
|
1.68%
|
1.16%
|
1.34%
|
1.98%
|
2.13%
|
2.15%
|
2.32%
|
Capitalization / Revenue
|
2.46
x
|
2.52
x
|
3.19
x
|
3.11
x
|
2.22
x
|
1.96
x
|
1.84
x
|
1.72
x
|
EV / Revenue
|
2.29
x
|
2.35
x
|
3.07
x
|
2.93
x
|
2.08
x
|
1.83
x
|
1.69
x
|
1.55
x
|
EV / EBITDA
|
17.9
x
|
17.4
x
|
21.5
x
|
23
x
|
14.6
x
|
14.4
x
|
12.8
x
|
11.6
x
|
EV / FCF
|
30
x
|
58
x
|
76.7
x
|
33.1
x
|
30.1
x
|
26.8
x
|
22.9
x
|
20.3
x
|
FCF Yield
|
3.33%
|
1.72%
|
1.3%
|
3.02%
|
3.32%
|
3.73%
|
4.37%
|
4.92%
|
Price to Book
|
3.08
x
|
3.15
x
|
4.14
x
|
4.09
x
|
3.17
x
|
2.99
x
|
2.82
x
|
2.64
x
|
Nbr of stocks (in thousands)
|
74,669
|
74,670
|
74,747
|
74,775
|
72,375
|
71,607
|
-
|
-
|
Reference price
2 |
2,200
|
2,380
|
3,478
|
3,620
|
2,805
|
2,638
|
2,638
|
2,638
|
Announcement Date
|
5/13/19
|
5/12/20
|
5/14/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
66,733
|
70,389
|
81,606
|
86,954
|
91,421
|
96,550
|
102,902
|
109,549
|
EBITDA
1 |
8,514
|
9,537
|
11,620
|
11,066
|
13,042
|
12,213
|
13,526
|
14,669
|
EBIT
1 |
7,562
|
8,550
|
9,891
|
9,341
|
11,396
|
10,572
|
11,917
|
13,039
|
Operating Margin
|
11.33%
|
12.15%
|
12.12%
|
10.74%
|
12.47%
|
10.95%
|
11.58%
|
11.9%
|
Earnings before Tax (EBT)
1 |
7,751
|
8,746
|
8,941
|
10,454
|
11,668
|
11,004
|
12,370
|
13,553
|
Net income
1 |
5,264
|
5,966
|
5,988
|
7,202
|
8,112
|
7,585
|
8,502
|
9,316
|
Net margin
|
7.89%
|
8.48%
|
7.34%
|
8.28%
|
8.87%
|
7.86%
|
8.26%
|
8.5%
|
EPS
2 |
70.50
|
79.90
|
80.14
|
96.34
|
109.4
|
103.9
|
116.5
|
127.6
|
Free Cash Flow
1 |
5,084
|
2,855
|
3,265
|
7,688
|
6,330
|
6,587
|
7,587
|
8,369
|
FCF margin
|
7.62%
|
4.06%
|
4%
|
8.84%
|
6.92%
|
6.82%
|
7.37%
|
7.64%
|
FCF Conversion (EBITDA)
|
59.71%
|
29.94%
|
28.1%
|
69.47%
|
48.54%
|
53.93%
|
56.1%
|
57.05%
|
FCF Conversion (Net income)
|
96.58%
|
47.86%
|
54.52%
|
106.75%
|
78.03%
|
86.84%
|
89.25%
|
89.83%
|
Dividend per Share
2 |
35.25
|
40.00
|
40.25
|
48.50
|
55.50
|
56.17
|
56.83
|
61.33
|
Announcement Date
|
5/13/19
|
5/12/20
|
5/14/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
32,594
|
35,289
|
20,399
|
40,462
|
21,317
|
25,175
|
-
|
20,471
|
22,126
|
42,597
|
23,322
|
25,502
|
21,735
|
22,378
|
44,113
|
24,538
|
27,324
|
52,237
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3,835
|
3,528
|
1,592
|
3,882
|
2,364
|
3,095
|
-
|
2,523
|
2,806
|
5,329
|
2,910
|
3,157
|
2,462
|
2,512
|
4,974
|
2,559
|
2,982
|
5,655
|
Operating Margin
|
11.77%
|
10%
|
7.8%
|
9.59%
|
11.09%
|
12.29%
|
-
|
12.32%
|
12.68%
|
12.51%
|
12.48%
|
12.38%
|
11.33%
|
11.23%
|
11.28%
|
10.43%
|
10.91%
|
10.83%
|
Earnings before Tax (EBT)
|
3,981
|
3,715
|
-
|
4,107
|
2,551
|
-
|
-
|
2,518
|
-
|
5,330
|
3,116
|
-
|
2,559
|
-
|
5,167
|
2,704
|
-
|
-
|
Net income
1 |
2,719
|
2,556
|
1,211
|
2,836
|
1,761
|
2,605
|
-
|
1,736
|
1,944
|
3,680
|
2,149
|
2,283
|
1,766
|
1,784
|
3,550
|
1,872
|
2,028
|
-
|
Net margin
|
8.34%
|
7.24%
|
5.94%
|
7.01%
|
8.26%
|
10.35%
|
-
|
8.48%
|
8.79%
|
8.64%
|
9.21%
|
8.95%
|
8.13%
|
7.97%
|
8.05%
|
7.63%
|
7.42%
|
-
|
EPS
|
36.42
|
34.22
|
-
|
37.95
|
47.08
|
-
|
-
|
23.22
|
-
|
49.26
|
28.81
|
-
|
24.40
|
-
|
49.05
|
25.84
|
-
|
-
|
Dividend per Share
|
20.75
|
15.00
|
-
|
22.00
|
-
|
-
|
26.50
|
-
|
-
|
24.00
|
-
|
-
|
-
|
-
|
25.00
|
-
|
-
|
-
|
Announcement Date
|
10/31/19
|
10/30/20
|
10/29/21
|
10/29/21
|
1/31/22
|
5/13/22
|
5/13/22
|
7/29/22
|
10/31/22
|
10/31/22
|
1/31/23
|
5/12/23
|
7/31/23
|
10/31/23
|
10/31/23
|
1/31/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
11,666
|
11,974
|
9,647
|
16,117
|
12,425
|
12,487
|
15,316
|
18,748
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
5,084
|
2,855
|
3,265
|
7,688
|
6,330
|
6,587
|
7,587
|
8,369
|
ROE (net income / shareholders' equity)
|
10%
|
10.9%
|
10.1%
|
11.2%
|
12.5%
|
11.7%
|
12.4%
|
12.8%
|
ROA (Net income/ Total Assets)
|
9.88%
|
11%
|
11.6%
|
10.1%
|
12%
|
7.45%
|
8.28%
|
8.76%
|
Assets
1 |
53,304
|
54,200
|
51,612
|
71,632
|
67,472
|
101,804
|
102,687
|
106,413
|
Book Value Per Share
2 |
713.0
|
757.0
|
840.0
|
885.0
|
884.0
|
881.0
|
937.0
|
999.0
|
Cash Flow per Share
2 |
81.70
|
91.60
|
102.0
|
119.0
|
132.0
|
99.50
|
112.0
|
125.0
|
Capex
1 |
1,181
|
4,309
|
2,189
|
1,152
|
639
|
2,224
|
1,136
|
1,001
|
Capex / Sales
|
1.77%
|
6.12%
|
2.68%
|
1.33%
|
0.7%
|
2.3%
|
1.1%
|
0.91%
|
Announcement Date
|
5/13/19
|
5/12/20
|
5/14/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Last Close Price
2,638
JPY Average target price
3,500
JPY Spread / Average Target +32.68% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.79% | 1.21B | | -0.44% | 1.45B | | -3.32% | 1.43B | | -14.59% | 899M | | +1.72% | 480M | | +3.85% | 440M | | -48.41% | 369M | | -19.75% | 356M | | -2.93% | 213M | | -28.04% | 209M |
Medical Equipment Wholesale
|